Cargando…

Interaction between warfarin and molnupiravir in a patient with coronavirus disease 2019 infection

Molnupiravir is a novel antiviral agent for coronavirus disease 2019 (COVID-19) treatment. Warfarin is an oral anticoagulation agent with difficult management due to drug interactions. Here, we describe a case of international normalized ratio (INR) prolongation in a patient who administrated warfar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizutani, Hikari, Koide, Tetsuro, Omura, Takashi, Ito, Kumiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041292/ https://www.ncbi.nlm.nih.gov/pubmed/36993011 http://dx.doi.org/10.4103/jfmpc.jfmpc_1387_22

Ejemplares similares

Phlegmasia cerulea dolens associated with acute coronavirus disease 2019 pneumonia despite supratherapeutic warfarin anticoagulation
por: Chun, Tristen T., et al.
Publicado: (2020)

Duloxetine-induced hyponatraemia in a patient with hypocortisolaemia
por: Ikeguchi, Mayuko, et al.
Publicado: (2020)

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic
por: Suzuki, Yasuhito, et al.
Publicado: (2022)

Moxifloxacin-warfarin interaction
por: Ji, Yan, et al.
Publicado: (2012)

Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)

Computational Analysis of Molnupiravir
por: Sharov, Artem V., et al.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Immunosuppressants exert differential effects on pan‐coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir
por: Wang, Yining, et al.
Publicado: (2023)

The critical interaction between valproate sodium and warfarin: case report and review
por: Zhou, Chenguang, et al.
Publicado: (2018)

What will be the role of molnupiravir in the treatment of COVID-19 infection?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report
por: Kato, Takashi, et al.
Publicado: (2023)

Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report
por: Jackevicius, Cynthia A., et al.
Publicado: (2009)

Molnupiravir Inhibits Porcine Epidemic Diarrhea Virus Infection In Vitro
por: Huang, Zi-Xin, et al.
Publicado: (2023)

Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections
por: Lin, Dan-Yu, et al.
Publicado: (2023)

In vitro and in vivo efficacy of Molnupiravir against Zika virus infections
por: Wang, Zhuang, et al.
Publicado: (2023)

Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses
por: Wang, Yining, et al.
Publicado: (2021)

Publisher Correction: Molnupiravir: coding for catastrophe
por: Malone, Brandon, et al.
Publicado: (2021)

Molnupiravir, une affaire franco-européenne
por: Manus, Jean-Marie
Publicado: (2021)

Molnupiravir: From Hope to Epic Fail?
por: Focosi, Daniele
Publicado: (2022)

Why Molnupiravir Fails in Hospitalized Patients
por: Brown, Ashley N., et al.
Publicado: (2022)

Case report on interaction of warfarin with herbal medicine “kadha”
por: Premchand, Rajendra Kumar, et al.
Publicado: (2021)

Natalizumab: Coronavirus disease-2019 infection: 6 case reports
Publicado: (2022)

An interaction between warfarin and cannabidiol, a case report
por: Grayson, Leslie, et al.
Publicado: (2017)

Interaction between Warfarin and the Herbal Product Shengmai-Yin: A Case Report of Intracerebral Hematoma
por: Su, Qun, et al.
Publicado: (2010)

Potential drug‐drug interaction between tolvaptan and warfarin in a geriatric patient with heart failure
por: Nimura, Satomi, et al.
Publicado: (2022)

Warfarin and phenytoin drug interaction with possible purple glove syndrome
por: Hunter, Carolyn S., et al.
Publicado: (2016)

Warfarin/herbal drink interaction: Elevated INR: case report
Publicado: (2021)

Case report: Medical cannabis—warfarin drug-drug interaction
por: Thomas, Tyan F., et al.
Publicado: (2022)

Suspected Tuberculous Pleurisy and Coronavirus Disease 2019 Comorbidity
por: Yamaguchi, Yoh, et al.
Publicado: (2021)

Transcriptional differences between coronavirus disease 2019 and bacterial sepsis
por: Ito, Hiroshi, et al.
Publicado: (2022)

Reticular skin eruption as the initial sign of coronavirus disease 2019 infection
por: Strom, Mark A., et al.
Publicado: (2020)

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
por: Bai, Yuan, et al.
Publicado: (2022)

Molnupiravir; molecular and functional descriptors of mitochondrial safety
por: Wallace, K.B., et al.
Publicado: (2022)

Efficacy and safety of molnupiravir for COVID-19 patients
por: Fatima, Maurish, et al.
Publicado: (2022)

Concise two-step chemical synthesis of molnupiravir
por: Pereira, Vinícius R. D., et al.
Publicado: (2022)

Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine
por: Tanaka, Tomohiro, et al.
Publicado: (2023)

Doxycycline in the Coronavirus Disease 2019 Therapy
por: Dorobisz, Karolina, et al.
Publicado: (2021)

Coronavirus Disease 2019 Presenting as Conjunctivitis
por: Ying, Ng Ying, et al.
Publicado: (2021)

Coronavirus disease 2019 with Chilaiditi sign
por: Tominaga, Yoshiteru, et al.
Publicado: (2023)

Coronavirus Disease 2019 Infection in Newborns
por: Perlman, Jeffrey M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q060d7olvm1s8gkkflm2fkq16l